Private Placement - Additional Information (Detail) - USD ($) |
12 Months Ended | ||||
---|---|---|---|---|---|
Nov. 13, 2019 |
Dec. 31, 2020 |
Mar. 31, 2021 |
Dec. 31, 2019 |
Nov. 05, 2019 |
|
Stock Issued During Period, Shares, New Issues | 31,625,000 | ||||
Private Placement Warrants [Member] | |||||
Exercise price of warrants | $ 0.62 | $ 1.50 | $ 2.37 | $ 0.91 | $ 0.62 |
Private Placement | Warrant | |||||
Shares issued, price per share | $ 1.00 | ||||
Exercise price of warrants | $ 11.50 | ||||
Number of shares of common stock issuable on exercise of each warrant | 1 | ||||
Additional Private Placement | Warrant | |||||
Stock Issued During Period, Shares, New Issues | 8,325,000 | ||||
Stock issued during period, value, new issues | $ 8,325,000 | ||||
IPO | Private Placement Warrants [Member] | |||||
Exercise price of warrants | $ 1 |
X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares. No definition available.
|
X | ||||||||||
- Definition Per share or per unit amount of equity securities issued. No definition available.
|
X | ||||||||||
- Definition Number of new stock issued during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|